SCHEMBL28869362

SCHEMBL28869362

[c]1ccccc1-c1cccc2ccoc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PTPRC P08575 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891238 0.74 GPR55 (0.41) MAPTMAPK1SMN1; SMN2TDP1L3MBTL1
SCHEMBL2761711 0.72 MEN1 (0.32) MEN1NPC1MAPTMAPK1RAB9A
SCHEMBL147800 0.72 POLB (0.40) CYP1A2CYP3A4MAPTMAPK1SMN1; SMN2
SCHEMBL28869311 0.71 XDH (0.33) SLC6A2SLC6A4SLC6A3MEN1NPC1
SCHEMBL8860550 0.71 ALDH1A1 (0.33) MAPK1L3MBTL1
SCHEMBL28592424 0.70 PTPRC (0.35) PTPRC
SCHEMBL322239 0.70 MEN1 (0.35) MEN1NPC1MAPTMAPK1RAB9A
SCHEMBL8855149 0.70 MEN1 (0.35) MEN1NPC1MAPTMAPK1RAB9A
SCHEMBL668821 0.69 POLB (0.38) CYP1A2CYP3A4MAPTMAPK1SMN1; SMN2
SCHEMBL28917485 0.69 GAA (0.37) MEN1NPC1CYP1A2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311844-A Triaizine compounds, its manufacturing method and the organic electroluminescent device as constituent 东曹株式会社 2019-02-05 CN disclosed